Warfarin and Cranberry Juice: Time to Lose the Warnings?

Expert Interview With Jack E. Ansell, MD

Linda Brookes, MSc


September 02, 2010

In This Article

A Best Evidence Interview With Jack E. Ansell, MD

The Best Evidence Study

Dr. Ansell is senior author of the following review:
Zikria J, Goldman R, Ansell J. Cranberry juice and warfarin: when bad publicity trumps science. Am J Med. 2010;123:384-392.

This study was selected as the subject of this interview because of its high ranking in Medscape Best Evidence, which uses the McMaster Online Rating of Evidence System. Of a possible score of 7, clinicians who used this system ranked this study as 6 for relevance and 5 for newsworthiness

About the Interviewee: Jack E. Ansell, MD

Jack E. Ansell, MD, is the Chairman of the Department of Medicine at Lenox Hill Hospital and Professor of Medicine, New York University School of Medicine, New York, NY. Dr. Ansell's main areas of research focus on the clinical problems of thrombosis, thrombotic disorders, and antithrombotic therapy. He has had a continued involvement in the application of new modes of delivering and monitoring anticoagulants, particularly in the management of oral anticoagulant therapy. He has been increasingly involved in the clinical study of new oral anticoagulants.

Dr. Ansell is the founder and immediate past Chair of the Anticoagulation Forum, a network of anticoagulation clinics throughout North America, and is a member of professional organizations, including the American College of Physicians (Fellow), the American Society of Hematology, the International Society of Thrombosis and Hemostasis, the American Heart Association (Fellow), and the American Medical Association. He is Chair of 2 consensus committees of the American College of Chest Physicians that are working to establish national guidelines on antithrombotic therapy. 

Dr. Ansell is the author of more than 200 publications, including original research, reviews, editorials, chapters, and books. He serves as Senior Associate Editor for the Journal of Thrombosis and Thrombolysis and as an editorial consultant for professional journals, including The New England Journal of Medicine, Blood, Journal of Thrombosis and Haemostasis, and Circulation.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.